Point-of-Care diagnostics of coagulation in the management of bleeding and transfusion in trauma patients.

PURPOSE OF REVIEW Trauma-associated bleeding and coagulopathy require timely identification, prevention, and effective treatment. The present review summarizes the recent literature around point-of-care (POC) coagulation tests, their usefulness in the management of trauma-induced coagulopathy (TIC), their impact on trauma patient outcomes, and the requirement of quality assurance. RECENT FINDINGS Best practice algorithms to manage TIC have been compiled in the 2019 European Guideline on the management of major bleeding and coagulopathy after trauma. Evidence supports the use of goal-directed approaches to manage TIC. POC coagulation tests can accelerate and tailor individualized therapies. Recent findings emphasize: the time sparing of POC tests in prehospital settings and the validity of POC measurements in extreme environments; the potential scalability of POC-guided TIC algorithms in burn injuries and the pediatric population; the need for careful considerations of strategies to monitor and reverse the effects of direct oral anticoagulants in major trauma. SUMMARY In contrast to an abundance of reviews and practical approaches to POC coagulation management in trauma patients, there is a scarcity of research in the field and large-scale clinical trials are urgently needed. The paneuropean multicenter trial Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy (iTACTIC) will inform on the potential of viscoelastic tests to augment transfusion protocols for better patient outcomes.

[1]  C. Mooney,et al.  Point of care testing in general haematology , 2019, British journal of haematology.

[2]  W. Voelckel,et al.  Idarucizumab in major trauma patients: a single centre real life experience , 2019, European Journal of Trauma and Emergency Surgery.

[3]  M. Wullschleger,et al.  Targeted fibrinogen concentrate use in severe traumatic haemorrhage. , 2019, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[4]  R. Rossaint,et al.  Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model. , 2019, British journal of anaesthesia.

[5]  J. Nurmi,et al.  Point‐of‐care analyses of blood samples from intraosseous access in pre‐hospital critical care , 2019, Acta anaesthesiologica Scandinavica.

[6]  M. Cohen,et al.  Trauma‐induced coagulopathy: The past, present, and future , 2019, Journal of thrombosis and haemostasis : JTH.

[7]  A. Brazinova,et al.  Protocolised thromboelastometric‐guided haemostatic management in patients with traumatic brain injury: a pilot study , 2019, Anaesthesia.

[8]  J. Vincent,et al.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition , 2019, Critical Care.

[9]  Kevin P. Blaine,et al.  Viscoelastic Monitoring to Guide the Correction of Perioperative Coagulopathy and Massive Transfusion in Patients with Life-Threatening Hemorrhage. , 2019, Anesthesiology clinics.

[10]  T. Matsuoka,et al.  Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study , 2019, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

[11]  C. Krall,et al.  Thrombin generation in patients with severe thermal injury. , 2019, Burns : journal of the International Society for Burn Injuries.

[12]  B. Bouillon,et al.  Trauma-induced coagulopathy upon emergency room arrival: still a significant problem despite increased awareness and management? , 2019, European Journal of Trauma and Emergency Surgery.

[13]  M. Maegele,et al.  Current strategies for hemostatic control in acute trauma hemorrhage and trauma-induced coagulopathy , 2018, Expert review of hematology.

[14]  Matthew Miller,et al.  The reliability of thromboelastography in a simulated rotary wing environment , 2018, Emergency Medicine Journal.

[15]  D. Dirkmann,et al.  Point-of-Care-Diagnostik in der Traumatologie – Methoden und Evidenz , 2018, AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie.

[16]  S. Kitchen,et al.  International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants , 2018, Thrombosis and Haemostasis.

[17]  P. Johansson,et al.  Early haemorrhage control and management of trauma-induced coagulopathy: the importance of goal-directed therapy , 2017, Current opinion in critical care.

[18]  S. Stanworth,et al.  iTACTIC – implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial , 2017, Trials.

[19]  J. Nurmi,et al.  Intraosseous blood samples for point-of-care analysis: agreement between intraosseous and arterial analyses , 2017, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

[20]  A. Mayr,et al.  Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. , 2017, The Lancet. Haematology.

[21]  A. Wareing Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding , 2017, International journal of nursing practice.

[22]  A. Hanke,et al.  Point-of-care monitoring for the management of trauma-induced bleeding , 2017, Current opinion in anaesthesiology.

[23]  N. Juffermans,et al.  Viscoelastic Testing in Trauma , 2017, Seminars in Thrombosis and Hemostasis.

[24]  S. Kozek-Langenecker,et al.  Point-of-Care Testing in Burn Patients , 2017, Seminars in Thrombosis and Hemostasis.

[25]  M. Ranucci,et al.  Point-of-Care Coagulation Tests Monitoring of Direct Oral Anticoagulants and Their Reversal Therapy: State of the Art , 2017, Seminars in Thrombosis and Hemostasis.

[26]  D. Spahn,et al.  Point-of-Care Coagulation Monitoring in Trauma Patients , 2017, Seminars in Thrombosis and Hemostasis.

[27]  U. Ziemann,et al.  Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants , 2017, Critical Care.

[28]  N. Ferreirós,et al.  Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients , 2017, Thrombosis and Haemostasis.

[29]  M. Maegele,et al.  Direct Oral Anticoagulants in Emergency Trauma Admissions. , 2016, Deutsches Arzteblatt international.

[30]  A. Sauaia,et al.  Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays , 2016, Annals of surgery.

[31]  W. Voelckel,et al.  Fixed ratio versus goal-directed therapy in trauma , 2016, Current opinion in anaesthesiology.

[32]  M. Hayakawa,et al.  Pathophysiology of Trauma-Induced Coagulopathy and Management of Critical Bleeding Requiring Massive Transfusion , 2015, Seminars in Thrombosis & Hemostasis.

[33]  R. Maier,et al.  An International Normalized Ratio–Based Definition of Acute Traumatic Coagulopathy Is Associated With Mortality, Venous Thromboembolism, and Multiple Organ Failure After Injury , 2015, Critical care medicine.

[34]  K. Inaba,et al.  2014 Consensus conference on viscoelastic test–based transfusion guidelines for early trauma resuscitation: Report of the panel , 2015, The journal of trauma and acute care surgery.

[35]  G. Nardi,et al.  Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs , 2015, Critical Care.

[36]  D. Spahn,et al.  Evidence Base for Restrictive Transfusion Triggers in High-Risk Patients , 2015, Transfusion Medicine and Hemotherapy.

[37]  David B Hoyt,et al.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. , 2015, JAMA.

[38]  O. Sakowitz,et al.  Point of care coagulation testing in neurosurgery , 2015, Journal of Clinical Neuroscience.

[39]  N. Adhikari,et al.  Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review , 2014, Critical Care.

[40]  D. Spahn,et al.  Applying ‘Patient Blood Management’ in the trauma center , 2014, Current opinion in anaesthesiology.

[41]  W. Voelckel,et al.  Platelet function following trauma , 2011, Thrombosis and Haemostasis.

[42]  W. Voelckel,et al.  Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy , 2011, Critical care.

[43]  R. Lefering,et al.  Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. , 2007, Injury.

[44]  Fevzi Sarper Türker Hemorrhagic Shock , 2020, Clinical Management of Shock - The Science and Art of Physiological Restoration.

[45]  M. Maegele,et al.  [Viscoelasticity-based treatment of bleeding injuries]. , 2017, Der Unfallchirurg.

[46]  P. Whiting,et al.  Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. , 2015, Health technology assessment.

[47]  R. Coimbra,et al.  A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients. , 2011, The Journal of trauma.